The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Abstract
Psychiatric disorders, including major depressive disorder (MDD), bipolar disorder (BD) and schizophrenia, affect a significant percentage of the world population. These disorders are associated with educational difficulties, decreased productivity and reduced quality of life, but their underlying pathophysiological mechanisms are not fully elucidated. Recently, studies have suggested that psychiatric disorders could be considered as inflammatory disorders, even though the exact mechanisms underlying this association are not known. An increase in inflammatory response and oxidative stress may lead to inflammation, which in turn can stimulate microglia in the brain. Microglial activation is roused by the M1 phenotype, which is associated with an increase in interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). On the contrary, M2 phenotype is associated with a release of anti-inflammatory cytokines. Thus, it is possible that the inflammatory response from microglial activation can contribute to brain pathology, as well as influence treatment responses. This review will highlight the role of inflammation in the pathophysiology of psychiatric disorders, such as MDD, BD, schizophrenia, and autism. More specifically, the role of microglial activation and associated molecular cascades will also be discussed as a means by which these neuroinflammatory mechanisms take place, when appropriate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation is also likely to be an aggravating factor in the effects of NMDAR hypofunction and oxidative stress: prenatal immune challenge by the viral mimetic Polyl:C causes a long-lasting sensitivity of the offspring to peri-pubertal stress and NMDAR antagonists 90 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [90]
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
Microglial and macrophage polarization—new prospects for brain repair
Hu, X., Leak, R. K., Shi, Y., Suenaga, J., Gao, Y., Zheng, P., & Chen, J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.207 · Cited by 1,366
Research works printed but not linked: 2
- Abelaira, 2014, Animal models as tools to study the pathophysiology of depression, Rev Bras Psiquiatr, 35, 112, 10.1590/1516-4446-2013-1098 · DOI
- Gubert, 2013, The P2X7 purinergic receptor as a molecular target in Bipolar Disorder, Neuropsychiat Neuropsychol, 8, 1
Cited by
Sorted by citations
Items 201–300 of 595
Ślusarczyk, J., Trojan, E., Wydra, K., Głombik, K., Chamera, K., Kucharczyk, M. W., Budziszewska, B., Kubera, M., Lasoń, W., Filip, M., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.05.008 · Cited by 41
Fallon, B. A., Madsen, T., Erlangsen, A., & Benros, M. E. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.20091347 · Cited by 39
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
Moos, W. H., Maneta, E., Pinkert, C. A., Irwin, M. H., Hoffman, M. E., Faller, D. V., & Steliou, K. (2016) · Drug Development Research · doi:10.1002/ddr.21295 · Cited by 41
Pandey, M. K. (2023) · Biomedicines · doi:10.3390/biomedicines11041067 · Cited by 40
Biological and pathophysiological roles of end-products of DHA oxidation
Yakubenko, V. P., & Byzova, T. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.09.022 · Cited by 39
Isung, J., Williams, K., Isomura, K., Gromark, C., Hesselmark, E., Lichtenstein, P., Larsson, H., de la Cruz, L. F., Sidorchuk, A., & Mataix‐Cols, D. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.1260 · Cited by 38
Low‐Dose Copper Exposure Exacerbates Depression‐Like Behavior in ApoE4 Transgenic Mice
Xu, J., He, K., Zhang, K., Yang, C., Nie, L., Dan, D., Liu, J., Zhang, C.-E., & Yang, X. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6634181 · Cited by 38
Henry, R. J., Kerr, D. M., Flannery, L. E., Killilea, M., Hughes, E. M., Corcoran, L., Finn, D. P., & Roche, M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.016 · Cited by 37
Lin, C., Chen, K., Yu, J., Feng, W., Fu, W., Yang, F., Zhang, X., & Chen, D. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03569-5 · Cited by 40
Stress, depression, and hippocampus: from biochemistry to electrophysiology
Idunkova, A., Lacinová, Ľ., & Hoppanová, L. (2023) · General Physiology and Biophysics · doi:10.4149/gpb_2023001 · Cited by 36
Islam, M. R., Sohan, M., Daria, S., Masud, A. A., Ahmed, M. U., Roy, A., & Shahriar, M. (2023) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320231198828 · Cited by 41
Peripheral adenosine levels in euthymic patients with bipolar disorder
Gubert, C., Moritz, C. E. J., Vasconcelos-Moreno, M. P., Tietbohl-Santos, B., Sartori, J., Fijtman, A., Kauer‐Sant’Anna, M., Kapczinski, F. P., Battastini, A. M. O., & Magalhães, P. V. D. S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.10.007 · Cited by 36
Self-citationZhang, Y., Xu, H., Zhang, F., Shao, F., Ellenbroek, B. A., Wang, J., & Wang, W. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.010 · Cited by 34
Arbo, B. D., Benetti, F., García‐Segura, L. M., & Ribeiro, M. F. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 40
Hennessy, M. B., Chun, K., & Capitanio, J. P. (2016) · Social Neuroscience · doi:10.1080/17470919.2016.1145595 · Cited by 36
Tran, T.-V., Shin, E., Nguyen, L. T. T., Lee, Y., Kim, D.-J., Jeong, J. H., Jang, C., Nah, S.-Y., Toriumi, K., Nabeshima, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0638-8 · Cited by 34
Sun, X., Zhang, T., Zhao, Y. D., Cai, E., Zhu, H., & Liu, S. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153348 · Cited by 34
Uchio, R., Kawasaki, K., Okuda-Hanafusa, C., Saji, R., Muroyama, K., Murosaki, S., Yamamoto, Y., & Hirose, Y. (2021) · Nutrition Journal · doi:10.1186/s12937-021-00748-8 · Cited by 42
Skorobogatov, K., Autier, V., Foiselle, M., Richard, J., Boukouaci, W., Wu, C., Raynal, S., Carbonne, C., Laukens, K., Meysman, P., et al. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100584 · Cited by 34
Rodriguez‐Zas, S. L., Wu, C., Southey, B. R., O’Connor, J. C., Nixon, S. E., Garcia, R., Zavala, C., Lawson, M. A., McCusker, R. H., Romanova, E. V., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.06.024 · Cited by 35
Pierozan, P., Biasibetti, H., Schmitz, F., Ávila, H., Parisi, M. M., Barbé-Tuana, F., Wyse, A., & Pessoa-Pureur, R. (2016) · Biochimica et Biophysica Acta · doi:10.1016/j.bbamcr.2016.09.014 · Cited by 30
Puy, V., Darwiche, W., Trudel, S., Gomila, C., Lony, C., Puy, L., Lefèbvre, T., Vitry, S., Boullier, A., Karim, Z., et al. (2018) · Glia · doi:10.1002/glia.23335 · Cited by 32
Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications
Burchi, E., & Pallanti, S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180426151746 · Cited by 32
Molecular alterations in the medial temporal lobe in schizophrenia
Bobilev, A. M., Perez, J. M., & Tamminga, C. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.001 · Cited by 34
Mograbi, K. D. M., Suchecki, D., da Silva, S. G., Covolan, L., & Hamani, C. (2020) · Stress · doi:10.1080/10253890.2020.1712355 · Cited by 35
Pseudopterosin A: Protection of Synaptic Function and Potential as a Neuromodulatory Agent
Caplan, S. L., Zheng, B., Dawson-Scully, K. D., White, C. A., & West, L. M. (2016) · Marine Drugs · doi:10.3390/md14030055 · Cited by 32
Anti-inflammatory effects of minocycline are mediated by retinoid signaling
Clemens, V., Regen, F., Bret, N. L., Heuser, I., & Hellmann‐Regen, J. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0460-x · Cited by 34
Özkartal, C. Ş., Tüzün, E., Küçükali, C. İ., Ulusoy, C. A., Giriş, M., & Arıcıoğlu, F. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146438 · Cited by 33
Nguyen, P. L., Bui, B. P., Lee, H., & Cho, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052527 · Cited by 31
Is There a Link between Oropharyngeal Microbiome and Schizophrenia? A Narrative Review
Martin, S., Foulon, A., El‐Hage, W., Dufour‐Rainfray, D., & Denis, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020846 · Cited by 31
Deltamethrin-Evoked ER Stress Promotes Neuroinflammation in the Adult Mouse Hippocampus
Hossain, M. M., Toltin, A. C., Gamba, L. M., & Molina, M. A. (2022) · Cells · doi:10.3390/cells11121961 · Cited by 33
Filho, A. J. M. C., Eyres, C., Blöbaum, L., Landwehr, A., & Tremblay, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16098 · Cited by 33
Li, B., Gao, Y., Zhang, W., & Xu, J. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24187 · Cited by 30
Karoly, H. C., Bidwell, L. C., Mueller, R. L., & Hutchison, K. E. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13592 · Cited by 30
Yan, X., An, Z., Huangfu, Y., Zhang, Y.-T., Li, C., Chen, X., Liu, P., & Gao, J. (2018) · Phytochemistry · doi:10.1016/j.phytochem.2018.12.011 · Cited by 30
The Role of Cathepsins in Memory Functions and the Pathophysiology of Psychiatric Disorders
Niemeyer, C., Matosin, N., Kaul, D., Philipsen, A., & Gassen, N. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00718 · Cited by 30
Afridi, R., Seol, S., Kang, H. J., & Suk, K. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114532 · Cited by 29
Agmatine as a novel candidate for rapid-onset antidepressant response
Valverde, A. P., Camargo, A., & Rodrigues, A. L. S. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i11.981 · Cited by 31
Update on Statin Treatment in Patients with Neuropsychiatric Disorders
Avan, R., Sahebnasagh, A., Hashemi, J., Monajati, M., Faramarzi, F., Henney, N. C., Montecucco, F., Jamialahmadi, T., & Sahebkar, A. (2021) · Life · doi:10.3390/life11121365 · Cited by 34
de Oliveira, L. R. S., Machado, F. S. M., Dias, I. R., Magalhães, C. O. D. E., Sousa, R. A. L. D., & Cassilhas, R. C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07156-z · Cited by 30
Cohen, S. S., Ke, X., Liu, Q., Fu, Q., Majnik, A. V., & Lane, R. H. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.09.010 · Cited by 30
Ashare, R. L., & Wetherill, R. R. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0946-3 · Cited by 29
The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application
Niu, Z., Yang, L., Wu, X., Zhu, Y., Chen, J., & Fang, Y. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00403-7 · Cited by 31
Zhang, J., Su, D., Liu, Q., Yuan, Q., Ouyang, Z., Wei, Y., Xiao, C., Li, L., Yang, C., Jiang, W., et al. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.06.003 · Cited by 30
Tassinari, M., Mottolese, N., Galvani, G., Ferrara, D., Gennaccaro, L., Loi, M., Medici, G., Candini, G., Rimondini, R., Ciani, E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158719 · Cited by 29
Muzio, L., Brambilla, V., Calcaterra, L., D’Adamo, P., Martino, G., & Benedetti, F. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.063 · Cited by 29
Hai-Na, Z., Xu-Ben, Y., Cong-Rong, T., Yan-Cheng, C., Fan, Y., Lei-Mei, X., Ruo-Lan, S., Ye-Zi, Ye-Xuan, W., & Jing, L. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05406-w · Cited by 29
Nazari, S., Pourmand, S. M., Motevaseli, E., & Hassanzadeh, G. (2023) · IUBMB Life · doi:10.1002/iub.2759 · Cited by 29
Sanabria‐Castro, A., Alape‐Girón, A., Flores-Díaz, M., Echeverri-McCandless, A., & Parajeles, A. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0091 · Cited by 31
Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS
Tymchuk, S., Gómez, D., Koenig, N., Gill, M. J., Fujiwara, E., & Power, C. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717737029 · Cited by 28
Ferrari, P., Parisi, M. M., Colombo, R., Becker, M. W., Fries, G. R., Ascoli, B. M., Géa, L. P., Kauer‐Sant’Anna, M., Kapczinski, F. P., Klamt, F., et al. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.1.103 · Cited by 28
Self-citationGaspar, R., Soares‐Cunha, C., Domingues, A. V., Coimbra, B., Baptista, F. I., Pinto, L., Ambrósio, A. F., Rodrigues, A. J., & Gomes, C. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.834821 · Cited by 31
Circuits Regulating Pleasure and Happiness in Bipolar Disorder
LOONEN, A. J. M. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00035 · Cited by 30
Inflammation as a Neurobiological Mechanism of Cognitive Impairment in Psychological Stress
Şahin, Ş. K., & Aslan, E. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2305101 · Cited by 29
Leffa, D. T., Caye, A., Santos, I. S., Matijasevich, A., Menezes, A. M. B., Wehrmeister, F. C., Oliveira, I. O., Vitola, E. S., Bau, C. H. D., Grevet, E. H., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.004 · Cited by 27
Wang, S., Gong, G., Zhong, S., Duan, J., Yin, Z., Chang, M., Wei, S., Jiang, X., Zhou, Y., Tang, Y., et al. (2019) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180162 · Cited by 27
Yamamoto, K., Yamada, H., Wakana, N., Kikai, M., Terada, K., Wada, N., Motoyama, S., Saburi, M., Sugimoto, T., Kami, D., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.115 · Cited by 26
Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry
Bortolasci, C. C., Spolding, B., Callaly, E., Martin, S., Panizzutti, B., Kidnapillai, S., Connor, T., Hasebe, K., Mohebbi, M., Dean, O. M., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy014 · Cited by 25
Association of Risk Factors and Comorbidities With Chronic Pain in the Elderly Population
Mookerjee, N., Schmalbach, N. K., Antinori, G., Thampi, S., Windle-Puente, D., Gilligan, A., Huy, H., Andrews, M., Sun, A., Gandhi, R., et al. (2024) · Journal of Primary Care & Community Health · doi:10.1177/21501319241233463 · Cited by 28
Bolotta, A., Visconti, P., Fedrizzi, G., Ghezzo, A., Marini, M., Manunta, P., Messaggio, E., Posar, A., Vignini, A., & Abruzzo, P. M. (2018) · Autism Research · doi:10.1002/aur.2002 · Cited by 25
Zhang, Z.-X., Li, E., Yan, J.-P., Fu, W., Shen, P., Tian, S., & You, Y. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101959 · Cited by 26
Ashton, M. M., Dean, O. M., Walker, A. J., Bortolasci, C. C., Ng, C. H., Hopwood, M., Harvey, B. H., Möller, M., McGrath, J. J., Marx, W., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00115 · Cited by 25
Associations Between Subclinical Inflammatory Markers and OCD: A Retrospective Study
Herdi, O., Akaslan, D. S., İlhan, R. S., Çolak, B., & Duman, B. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113065 · Cited by 26
Huang, K., Kang, Y., Wu, Z., Wang, Y., Cai, S., & Huang, L. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110322 · Cited by 23
Takahashi, A., Aleyasin, H., Stavarache, M. A., Li, L., Cathomas, F., Parise, L. F., Lin, H., Burnett, C. J., Aubry, A., Flanigan, M. E., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01110-4 · Cited by 25
Lara-Espinosa, J. V., Arce-Aceves, M. F., López-Torres, M. O., Lozano-Ordaz, V., Mata‐Espinosa, D., Barrios‐Payán, J., Silva‐Islas, C. A., Maldonado, P. D., Marquina‐Castillo, B., & Hernández‐Pando, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041964 · Cited by 23
Perez, C. F., Escrivá‐Martínez, T., Montagud‐Romero, S., Ballestín, R., Reguilón, M. D., Miñarro, J., & Rodríguez‐Arias, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209291 · Cited by 24
Sakai, M., Yu, Z., Taniguchi, M., Picotin, R., Oyama, N., Stellwagen, D., Ono, C., Kikuchi, Y., Matsui, K., Nakanishi, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043798 · Cited by 25
Zhang, Y., Yin, J., Yan, H., Yan, L., Li, Y., Zhang, C., Li, Y., Liu, B., Lin, J., Zhang, L., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1163764 · Cited by 25
Food allergy induces alteration in brain inflammatory status and cognitive impairments
Liqing, Z., Chen, L., Li, X., Li, T., Dong, Z., & Wang, Y. T. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.011 · Cited by 24
Differential effects of typical and atypical antipsychotics on astroglial cells in vitro
Bobermin, L. D., da Silva, A., Souza, D. O., & Quincozes‐Santos, A. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.06.001 · Cited by 23
Gilman, T. L., Mitchell, N. C., Daws, L. C., & Toney, G. M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy099 · Cited by 22
Church, J. S., Renzelman, M. L., & Schwartzer, J. J. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108903 · Cited by 26
Microglia as a Hub for Suicide Neuropathology: Future Investigation and Prevention Targets
de Andrade, E. G., Ibáñez, F. G., & Tremblay, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.839396 · Cited by 22
Wei, Y., Xiao, L., Fan, W., Zou, J., Yang, H., Liu, B., Ye, Y., Wen, D., & Liao, L. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02046-2 · Cited by 23
Skorobogatov, K., Picker, L. D., Wu, C., Foiselle, M., Richard, J., Boukouaci, W., Bouassida, J., Laukens, K., Meysman, P., Corvoisier, P. L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.08.013 · Cited by 23
Abelaira, H. M., Réus, G. Z., Ignácio, Z. M., dos Santos, M. A. B., de Moura, A. B., Matos, D., Demo, J. P., da Silva, J. B. I., Danielski, L. G., Petronilho, F. C., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0071-4 · Cited by 22
Self-citationTodorović, N., & Filipović, D. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.044 · Cited by 24
Costa, G., Porceddu, P. F., Serra, M., Casu, M. A., Schiano, V., Napolitano, F., Pinna, A., Usiello, A., & Morelli, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071556 · Cited by 22
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 20
Low income and schizophrenia risk: A narrative review
Schneider, M., Müller, C. P., & Knies, A. K. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114047 · Cited by 26
Psychosis in Parkinson's disease: From the soft signs to the hard science
Lenka, A., Herath, P., Christopher, R., & Pal, P. K. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.06.011 · Cited by 21
Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
Haroon, E., & Miller, A. H. (2017) · Modern trends in psychiatry · doi:10.1159/000470805 · Cited by 22
Cathepsin B inhibition ameliorates leukocyte‐endothelial adhesion in the BTBR mouse model of autism
Wang, H., Yin, Y., Gong, D., Hong, L., Wu, G., Jiang, Q., Wang, C., Blinder, P., Long, S., Han, F., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13074 · Cited by 20
Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
Mas, C. D., Nani, J., Noto, C., Yonamine, C., da Cunha, G. R., Mansur, R., Ota, V., Belangero, S., Cordeiro, Q., Kapczinski, F., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.02.021 · Cited by 19
Self-citationvan Rees, G. F., Lago, S. G., Cox, D., Tomasik, J., Rustogi, N., Weigelt, K., Özcan, S., Cooper, J. D., Drexhage, H. A., Leweke, F. M., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.003 · Cited by 22
Sex-related patterns of the gut-microbiota-brain axis in the neuropsychiatric conditions
Manosso, L. M., Lin, J. H. X., Carlessi, A. S., Recco, K. C. C., Quevedo, J., Gonçalves, C. L., & Réus, G. Z. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.001 · Cited by 23
Self-citationГеннадьевна, Ш. И., Tuchina, O. P., Sidorova, M. V., Levina, A. S., Khlebaeva, D. A., Vaido, A. I., & Dyuzhikova, N. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255380 · Cited by 20
Cytokine profile in drug-naïve panic disorder patients
Quagliato, L. A., & Nardi, A. E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01835-y · Cited by 20
Zhang, P., Fang, H., Lou, C., Ye, S., Shen, G., Chen, S., Amin, N., Botchway, B. O. A., & Fang, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.901093 · Cited by 20
Omeiza, N. A., Bakre, A. G., Ben‐Azu, B., Sowunmi, A. A., Abdulrahim, H. A., Chimezie, J., Lawal, S. O., Adebayo, O. G., Alagbonsi, A. I., Akinola, O., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115767 · Cited by 20
Association of viral hepatitis and bipolar disorder: a nationwide population-based study
Chong, L.-W., Hsu, C.-C., Lee, C., Chou, R., Lin, C., Chang, K., & Hsu, Y. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1542-3 · Cited by 21
Prolonged lipopolysaccharide exposure induces transient immunosuppression in BV2 microglia
Twayana, K. S., Chaudhari, N. D., & Ravanan, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27064 · Cited by 19
Lu, W., Pikhart, H., Peasey, A., Kubínová, R., Pitman, A., & Bobák, M. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.070 · Cited by 20
Brett, B. L., Savitz, J. B., Nitta, M. E., España, L. Y., Teague, T. K., Nelson, L. D., McCrea, M., & Meier, T. B. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.07.024 · Cited by 21
Martins, D., Dipasquale, O., Davies, K. A., Cooper, E., Tibble, J. A., Veronese, M., Frigo, M., Williams, S., Turkheimer, F., Cercignani, M., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.03.004 · Cited by 20
Suhara, T., Chaki, S., Kimura, H., Furusawa, M., Matsumoto, M., Ogura, H., Negishi, T., Saijo, T., Higuchi, M., Omura, T., et al. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw111 · Cited by 19
Tunç, S., Atagün, M. İ., Neşeli̇oğlu, S., Yenilmez, Y., Başbuğ, H. S., & Erel, Ö. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1517466 · Cited by 20
Cannabis in the Treatment of Traumatic Brain Injury: A Primer for Clinicians
Grenier, K., Ponnambalam, F., Lee, D. M., Lauwers, R., & Bhalerao, S. (2019) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2019.298 · Cited by 19
Tuon, T., Meirelles, S. S., de Moura, A. B., Rosa, T., Borba, L. A., Botelho, M. E. M., Abelaira, H. M., de Mathia, G. B., Danielski, L. G., Fileti, M. E., et al. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113226 · Cited by 19
Self-citation
Metadata
- Authors
- Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J.
- Affiliations
- Universidade do Extremo Sul Catarinense (BR)
- Universidade Federal do Rio Grande do Sul (BR)
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Réus, G.Z.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 300
- Pages
- 141-154
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W297523562
- Cited by
- 594
- References
- 168
- Citations by year
- 2026: 30 · 2025: 42 · 2024: 33 · 2023: 42 · 2022: 69 · 2021: 69 · 2020: 55 · 2019: 76 · 2018: 56 · 2017: 46 · 2016: 58 · 2015: 17
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- CNPq
- FAPESC
- UNESC
- ĹOréal/UNESCO/ABC Brazil Fellowship for Women in Science 2011
- The University of Texas Medical School at Houston
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- neuroinflammation, microglial activation, mental illness, major depressive disorder, bipolar disorder, schizophrenia, autism spectrum disorder, M1/M2 microglial polarization, IL-1β, TNF-α, oxidative stress, anti-inflammatory cytokines, treatment response
- MeSH terms
- Animals, Mental Disorders, Brain, Humans, Inflammation, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review